{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:15:29Z","timestamp":1792181729191,"version":"4.4.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T00:00:00Z","timestamp":1655942400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UC7AI094660"],"award-info":[{"award-number":["UC7AI094660"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007865","name":"University of Texas Medical Branch","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.celrep.2022.111094","type":"journal-article","created":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T18:16:35Z","timestamp":1658254595000},"page":"111094","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["A recombinant VSV-vectored vaccine rapidly protects nonhuman primates against heterologous lethal Lassa fever"],"prefix":"10.1016","volume":"40","author":[{"given":"Robert W.","family":"Cross","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"Woolsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek N.","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktoriya","family":"Borisevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krystle N.","family":"Agans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Deer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan B.","family":"Geisbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie S.","family":"Dobias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karla A.","family":"Fenton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas W.","family":"Geisbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2022.111094_bib1","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1038\/s41467-018-06741-w","article-title":"Non-neutralizing antibodies elicited by recombinant Lassa-Rabies vaccine are critical for protection against Lassa fever","volume":"9","author":"Abreu-Mota","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2022.111094_bib2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s42003-020-01543-7","article-title":"Systemic viral spreading and defective host responses are associated with fatal Lassa fever in macaques","volume":"4","author":"Baillet","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.celrep.2022.111094_bib3","doi-asserted-by":"crossref","first-page":"5890","DOI":"10.1128\/JVI.01948-08","article-title":"Early and strong immune responses are associated with control of viral replication and recovery in lassa virus-infected cynomolgus monkeys","volume":"83","author":"Baize","year":"2009","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2022.111094_bib4","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1089\/15303660160025903","article-title":"Lassa fever in Guinea: I. Epidemiology of human disease and clinical observations","volume":"1","author":"Bausch","year":"2001","journal-title":"Vector Borne Zoonotic Dis."},{"key":"10.1016\/j.celrep.2022.111094_bib5","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/1743-422X-7-279","article-title":"Lassa virus-like particles displaying all major immunological determinants as a vaccine candidate for Lassa hemorrhagic fever","volume":"7","author":"Branco","year":"2010","journal-title":"Virol. J."},{"key":"10.1016\/j.celrep.2022.111094_bib6","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.virol.2005.12.001","article-title":"A recombinant Yellow Fever 17D vaccine expressing Lassa virus glycoproteins","volume":"345","author":"Bredenbeek","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.celrep.2022.111094_bib7","doi-asserted-by":"crossref","first-page":"e02230-17","DOI":"10.1128\/JVI.02230-17","article-title":"A vaccine platform against arenaviruses based on a recombinant hyperattenuated Mopeia virus expressing heterologous glycoproteins","volume":"92","author":"Carnec","year":"2018","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2022.111094_bib8","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1080\/21645515.2017.1356500","article-title":"A DNA vaccine delivered by dermal electroporation fully protects cynomolgus macaques against Lassa fever","volume":"13","author":"Cashman","year":"2017","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.celrep.2022.111094_bib10","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.coviro.2019.07.003","article-title":"Antibody therapy for Lassa fever","volume":"37","author":"Cross","year":"2019","journal-title":"Curr. Opin. in Virol."},{"key":"10.1016\/j.celrep.2022.111094_bib11","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1172\/JCI131958","article-title":"Quadrivalent VesiculoVax vaccine protects nonhuman primates from viral-induced hemorrhagic fever and death","volume":"130","author":"Cross","year":"2020","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.celrep.2022.111094_bib12","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41541-021-00291-x","article-title":"ChAdOx1-vectored Lassa fever vaccine elicits a robust cellular and humoral immune response and protects Guinea pigs against lethal Lassa virus challenge","volume":"6","author":"Fischer","year":"2021","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.celrep.2022.111094_bib13","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/jmv.1890260204","article-title":"Hematologic dysfunction in Lassa fever","volume":"26","author":"Fisher-Hoch","year":"1988","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.celrep.2022.111094_bib14","doi-asserted-by":"crossref","first-page":"6777","DOI":"10.1128\/JVI.74.15.6777-6783.2000","article-title":"Effective vaccine for lassa fever","volume":"74","author":"Fisher-Hoch","year":"2000","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2022.111094_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000836","article-title":"T cell-dependence of Lassa fever pathogenesis","volume":"6","author":"Flatz","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.celrep.2022.111094_bib16","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2200065119","article-title":"A recombinant VSV-vectored vaccine rapidly protects nonhuman primates against lethal Nipah virus disease","volume":"119","author":"Foster","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2022.111094_bib17","doi-asserted-by":"crossref","first-page":"S783","DOI":"10.1093\/clinids\/11.Supplement_4.S783","article-title":"Clinical features of Lassa fever in Liberia","volume":"11","author":"Frame","year":"1989","journal-title":"Rev. Infect. Dis."},{"key":"10.1016\/j.celrep.2022.111094_bib18","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1371\/journal.pmed.0020183","article-title":"Development of a new vaccine for the prevention of Lassa fever","volume":"2","author":"Geisbert","year":"2005","journal-title":"PLoS Med."},{"key":"10.1016\/j.celrep.2022.111094_bib19","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(16)32621-6","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola \u00c7a Suffit!)","volume":"389","author":"Henao-Restrepo","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.celrep.2022.111094_bib20","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/1743-422X-8-205","article-title":"Pathogenesis of Lassa fever in cynomolgus macaques","volume":"8","author":"Hensley","year":"2011","journal-title":"Virol. J."},{"key":"10.1016\/j.celrep.2022.111094_bib21","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1146\/annurev.immunol.20.100301.064807","article-title":"Protein kinase c\u03b8 in T\u00a0cell activation","volume":"20","author":"Isakov","year":"2002","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.celrep.2022.111094_bib22","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/0035-9203(85)90388-8","article-title":"Endemic Lassa fever in Liberia. IV. Selection of optimally effective plasma for treatment by passive immunization","volume":"79","author":"Jahrling","year":"1985","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.celrep.2022.111094_bib23","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nm1258","article-title":"Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses","volume":"11","author":"Jones","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2022.111094_bib24","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1126\/science.aau9343","article-title":"Metagenomic sequencing at the epicenter of the Nigeria 2018 Lassa fever outbreak","volume":"363","author":"Kafetzopoulou","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.celrep.2022.111094_bib25","doi-asserted-by":"crossref","first-page":"599","DOI":"10.4161\/hv.23241","article-title":"Relevance of a pre-existing measles immunity prior immunization with a recombinant measles virus vector","volume":"9","author":"Knuchel","year":"2013","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.celrep.2022.111094_bib26","doi-asserted-by":"crossref","first-page":"13934","DOI":"10.1128\/JVI.79.22.13934-13942.2005","article-title":"A live attenuated vaccine for Lassa fever made by reassortment of Lassa and Mopeia viruses","volume":"79","author":"Lukashevich","year":"2005","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2022.111094_bib27","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nri1632","article-title":"NFAT proteins: key regulators of T-cell development and function","volume":"5","author":"Macian","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.celrep.2022.111094_bib28","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3201\/eid2102.141649","article-title":"Vesicular stomatitis virus-based vaccines against Lassa and Ebola viruses","volume":"21","author":"Marzi","year":"2015","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.celrep.2022.111094_bib29","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1126\/science.aab3920","article-title":"VSV-EBOV rapidly protects macaques against infection with the 2014\/15 Ebola virus outbreak strain","volume":"349","author":"Marzi","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.celrep.2022.111094_bib30","doi-asserted-by":"crossref","first-page":"774026","DOI":"10.3389\/fimmu.2021.774026","article-title":"Single dose of a VSV-based vaccine rapidly protects macaques from Marburg virus disease","volume":"12","author":"Marzi","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2022.111094_bib31","doi-asserted-by":"crossref","first-page":"eabf6348","DOI":"10.1126\/scitranslmed.abf6348","article-title":"A single-shot Lassa vaccine induces long-term immunity and protects cynomolgus monkeys against heterologous strains","volume":"13","author":"Mateo","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.celrep.2022.111094_bib32","first-page":"75","article-title":"Lassa fever","volume":"262","author":"McCormick","year":"2002","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.celrep.2022.111094_bib33","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/infdis\/155.3.445","article-title":"A case-control study of the clinical diagnosis and course of Lassa fever","volume":"155","author":"McCormick","year":"1987","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.celrep.2022.111094_bib34","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/infdis\/155.3.437","article-title":"A prospective study of the epidemiology and ecology of Lassa fever","volume":"155","author":"McCormick","year":"1987","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.celrep.2022.111094_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jmv.1890370102","article-title":"Inactivated Lassa virus elicits a non protective immune response in rhesus monkeys","volume":"37","author":"McCormick","year":"1992","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.celrep.2022.111094_bib36","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1038\/nm.4396","article-title":"Human-monoclonal-antibody therapy protects nonhuman primates against advanced Lassa fever","volume":"23","author":"Mire","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2022.111094_bib37","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nmeth.3337","article-title":"Robust enumeration of cell subsets from tissue expression profiles","volume":"12","author":"Newman","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.celrep.2022.111094_bib38","first-page":"1","article-title":"Lassa fever in West African sub-region: an overview","volume":"44","author":"Ogbu","year":"2007","journal-title":"J.\u00a0Vector Borne Dis."},{"key":"10.1016\/j.celrep.2022.111094_bib39","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41541-020-0179-4","article-title":"Rapid dose-dependent Natural Killer (NK) cell modulation and cytokine responses following human rVSV-ZEBOV Ebolavirus vaccination","volume":"5","author":"Pejoski","year":"2020","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.celrep.2022.111094_bib40","doi-asserted-by":"crossref","first-page":"11677","DOI":"10.1128\/JVI.75.23.11677-11685.2001","article-title":"Individual and bivalent vaccines based on alphavirus replicons protect Guinea pigs against infection with Lassa and Ebola viruses","volume":"75","author":"Pushko","year":"2001","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2022.111094_bib41","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1002\/eji.201142099","article-title":"NK cells are strongly activated by Lassa and Mopeia virus-infected human macrophages in\u00a0vitro but do not mediate virus suppression","volume":"42","author":"Russier","year":"2012","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.celrep.2022.111094_bib42","doi-asserted-by":"crossref","first-page":"e2748","DOI":"10.1371\/journal.pntd.0002748","article-title":"Lassa fever in post-conflict Sierra Leone","volume":"8","author":"Shaffer","year":"2014","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.celrep.2022.111094_bib43","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201731","article-title":"Virus-specific NK cell memory","volume":"218","author":"Sheppard","year":"2021","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.celrep.2022.111094_bib44","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41541-019-0104-x","article-title":"A recombinant vesicular stomatitis-based Lassa fever vaccine elicits rapid and long-term protection from lethal Lassa virus infection in Guinea pigs","volume":"4","author":"Stein","year":"2019","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.celrep.2022.111094_bib45","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1093\/infdis\/175.3.524","article-title":"Protective immunity in macaques vaccinated with live attenuated, recombinant, and subunit measles vaccines in the presence of passively acquired antibodies","volume":"175","author":"van Binnendijk","year":"1997","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.celrep.2022.111094_bib46","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.ebiom.2019.01.048","article-title":"HLA-C-restricted viral epitopes are associated with an escape mechanism from KIR2DL2(+) NK cells in Lassa virus infection","volume":"40","author":"Wauquier","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.celrep.2022.111094_bib47","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3201\/eid2403.171905","article-title":"New lineage of lassa virus, Togo, 2016","volume":"24","author":"Whitmer","year":"2018","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.celrep.2022.111094_bib48","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1089\/vim.2014.0069","article-title":"VSV\u0394G\/EBOV GP-induced innate protection enhances natural killer cell activity to increase survival in a lethal mouse adapted Ebola virus infection","volume":"28","author":"Williams","year":"2015","journal-title":"Viral Immunol."},{"key":"10.1016\/j.celrep.2022.111094_bib49","doi-asserted-by":"crossref","first-page":"taaa035","DOI":"10.1093\/jtm\/taaa035","article-title":"Fifty years of imported Lassa fever: a systematic review of primary and secondary cases","volume":"27","author":"Wolf","year":"2020","journal-title":"J.\u00a0Travel. Med."},{"key":"10.1016\/j.celrep.2022.111094_bib50","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1038\/s41598-020-59976-3","article-title":"Immune correlates of postexposure vaccine protection against Marburg virus","volume":"10","author":"Woolsey","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.celrep.2022.111094_bib51","doi-asserted-by":"crossref","first-page":"e0010433","DOI":"10.1371\/journal.pntd.0010433","article-title":"A highly attenuated Vesiculovax vaccine rapidly protects nonhuman primates against lethal Marburg virus challenge","volume":"16","author":"Woolsey","year":"2022","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.celrep.2022.111094_bib54","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1080\/22221751.2020.1796528","article-title":"Lassa fever in Benin: description of the 2014 and 2016 epidemics and genetic characterization of a new Lassa virus","volume":"9","author":"Yadouleton","year":"2020","journal-title":"Emerg Microbes Infect."},{"key":"10.1016\/j.celrep.2022.111094_bib55","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.3390\/v4102031","article-title":"Pathogenesis of lassa fever","volume":"4","author":"Yun","year":"2012","journal-title":"Viruses"}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124722008968?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124722008968?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T11:48:24Z","timestamp":1761911304000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124722008968"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S2211124722008968"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2022.111094","relation":{},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A recombinant VSV-vectored vaccine rapidly protects nonhuman primates against heterologous lethal Lassa fever","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2022.111094","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s).","name":"copyright","label":"Copyright"}],"article-number":"111094"}}